Is superdrol really more dangerous than other orals?

Yes, statistically. Nasr 2009 and case literature document several acute hepatic failures and acute kidney injuries in young men under superdrol at recreational doses (10-20 mg/d × 3-4 weeks), sometimes requiring hospitalization and dialysis. No other commercialized oral generates as many reports for such modest doses. Probable origin: combination of 17α methylation + 2,17α-dimethyl modification that saturates hepatic detoxification pathways more than other compounds and increases cholestasis risk.

Why was superdrol pulled from the market?

Initially sold as 'legal prohormone' under American legislative loophole in the 2000s, the FDA and DEA reclassified it as a controlled substance after accumulation of serious adverse event cases (cholestasis, hepatic failure, kidney failure, malignant hypertension). The compound remains accessible on the underground market and in some 'gray market' supplements, often under various commercial names. Its anti-doping classification is total (banned in and out of competition).

How much realistic gains with superdrol?

Over 4 weeks at 15 mg/d as kickstart of a 500 mg/week testo cycle: +4 to +7 kg raw mass, with little water retention ('dry' effect). Net gains retained at 3 months post-PCT: +3 to +5 kg of real muscle attributable to superdrol alone. It is very effective per mg, but the risk/benefit ratio is unfavorable compared to a dianabol 30 mg/d kickstart (net gains +2-3 kg with less severe hepatic profile).

Do you need hepatoprotectors under superdrol?

Imperative. TUDCA 500-1000 mg/d (the most documented for 17α-alkylated cholestasis), NAC 600 mg × 2 (hepatocyte regeneration), milk thistle 600 mg. These supplements do not prevent toxicity but can attenuate cholestasis and accelerate regeneration. Biological monitoring (ALT, AST, GGT, weekly total and direct bilirubin) remains non-negotiable. Any ALT elevation > 5× normal or bilirubin > 2× requires immediate stop.

Does anadrol also cause renal problems?

Less frequently than superdrol, but yes. The marked water retention and hypertension induced by anadrol can stress renal function, especially in users already with borderline eGFR. Documented cases of glomerulonephritis and acute kidney injury on anadrol cycles at 100+ mg/d in users who also consumed excess creatine and insufficient water. Creatinine and eGFR monitoring at W0, W2, W4 under high-dose anadrol cycle.

PCT after superdrol or anadrol cycle?

Intensive scheme. Start 3-4 days after last intake. hCG 1500 IU EOD × 10 days to restart atrophied testicles. Then clomid 50/50/25/25 mg × 4-6 weeks + nolvadex 20/20/10/10 mg (essential after anadrol to block indirect estrogenic rebounds on withdrawal). Complete panel T total, LH, FSH, E2, ALT/AST at W6 post-PCT. Imperative 12+ week hepatic break before any new oral. Cycle resumption only after complete hepatic panel back to normal.

Is there a safer alternative to superdrol?

For 'dry' kickstart without retention: turinabol 40-60 mg/d × 6 weeks offers 70% of superdrol effect with markedly more tolerable hepatic profile (still toxic but without documented extreme cases). For more potent mass kickstart: anadrol 50 mg/d × 4 weeks at high but documented/manageable hepatic risk. Superdrol is only justified in tight competition accepting the inherent risk — for recreational use, safer alternatives exist.

What specific renal monitoring under superdrol?

Creatinine and eGFR panel at W0 and every 2 weeks during cycle. Monitor microscopic hematuria (urine strip), low back pain, foamy urine (proteinuria). Hydration is critical: minimum 4 L of water per day, strict restriction of creatine and renal supplements. Any sign (pain, oliguria, dark urine) should lead to immediate stop with nephrology consultation. Superdrol renal toxicity appears cumulative and sometimes irreversible in some users.

Superdrol vs Anadrol: complete comparison (extreme orals, mass)

Critère	superdrol	anadrol
Anabolic/androgenic ratio	400:20	320:45
Half-life	~6-8 h	~9 h
Aromatization	No	No (but indirect estro effect)
Water retention	Minimal	Very marked
Hepatotoxicity	EXTREME (cases cholestasis + AKI)	Very high
Typical dose	10-20 mg/d	50-100 mg/d
Max duration	3-4 weeks	3-4 weeks
Gains 4 wk	+4-7 kg (dry)	+6-10 kg (wet + retention)

Quand choisir superdrol

Superdrol (methasterone) is one of the most dangerous orals ever commercialized. Initially sold as 'legal prohormone' in the United States in the 2000s then pulled from the market after several documented cases of acute hepatic and renal failure (Nasr 2009: severe intrahepatic cholestasis + acute kidney injury in young man under superdrol 20 mg/d × 3 weeks). Choose it only if you are an advanced competitor accepting major cardiovascular and hepatic risk, on very short cycles (3-4 weeks maximum) for: (1) a 'dry' kickstart without water retention, (2) a competitive window requiring +4-7 kg apparent lean mass in short time. Effects expected from D5-D7: intense muscle pump, rapidly rising strength, dry skin and visual hardness. Hormonal profile (Kicman 2008): no aromatization, severe and rapid HPG suppression, moderate androgenic profile. Documented side effects (Niedfeldt 2018, Nasr 2009): systematic and sometimes extreme ALT/AST elevation, intrahepatic cholestasis, hypertension, hematuria, low back pain (sign of renal involvement). Dose 10-20 mg/d × 3-4 weeks maximum, never without testosterone base, weekly hepatic and renal monitoring. Hepatoprotectors (TUDCA 1000 mg/d, NAC 1200 mg) imperative.

Quand choisir anadrol

Anadrol (oxymetholone) is the most potent oral in terms of raw mass, Hengge 2003 documenting +8.2 kg in 16 weeks at 150 mg/d in HIV-wasting patients. Choose it for: (1) a maximum kickstart over 3-4 weeks before a long ester takes over, (2) breaking through a plateau mid-cycle. Reserved for advanced users (Niedfeldt 2018, Pope 2014): very high hepatotoxic profile (intrahepatic cholestasis and hepatic peliosis documented at 100 mg/d × 8 weeks), indirect estrogenic effects despite no aromatization (oxymetholone interacts directly with muscular and mammary estrogen receptor — gynecomastia can appear without elevated estradiol, an AI alone is ineffective, workaround: SERM nolvadex 20-40 mg/d in parallel). Sometimes unmanageable BP, psychological effects (irritability, post-cycle anhedonia) reported in ~30% of users. Typical dose 50-75 mg/d × 3-4 weeks maximum, with minimum 8-week hepatic break before any other oral. Water and glycogen retention gives spectacular 'full' muscle effect during cycle, but 30-50% of visible kilos leave on cessation.

Combinaison ?

The superdrol + anadrol combo is strictly to be avoided: two 17α-alkylated drugs with toxicity among the highest ever commercialized, stacking that can cause acute hepatic failure documented in case literature (Nasr 2009 and other published clinical reports). If you absolutely want both effects, structure in sequence on different, well-separated cycles: an offseason cycle with anadrol kickstart (50 mg/d × 3 weeks), then 12 weeks off-oral and complete hepatic panel back to normal, then competitive window with superdrol (10-15 mg/d × 3 weeks maximum). Always on strong testosterone base (500 mg/week) to ensure androgenic function during cycle. Mandatory monitoring: ALT, AST, GGT, total and direct bilirubin, creatinine, eGFR, CBC, complete lipids at W0 then every week during oral block, then again at W2 and W4 post-cycle. Hepatoprotectors (TUDCA 500-1000 mg/d, NAC 1200 mg, milk thistle 600 mg). Any persistent low back pain, dark urine, skin pruritus or jaundice should lead to immediate stop and hepatology/nephrology consultation. No physician would validate this sequential combination — it is a strictly competition-assumed risk. Sample worst-case sequential timeline (only if absolutely justified by competition): W0 complete baseline panel including hepatology and nephrology consultation, W1-W3 anadrol 50 mg/d with weekly ALT/AST/bilirubin/creatinine, W3 anadrol stop, W4-W15 hepatic recovery with biweekly ALT/AST until normalized, W16 if normal then superdrol 10-15 mg/d × 3 weeks max with weekly all panels, W19 superdrol stop, W22 final hepatic recheck, W22 PCT start. Total annual exposure to either compound should ideally not exceed 4 weeks cumulative. Practical psychological consideration: both compounds can affect mood and aggression — communicate with training partners, family, coach. Cardio support: zone 2 cardio 30-45 min × 4-5 times per week is non-negotiable during exposure.

FAQ

Is superdrol really more dangerous than other orals?: Yes, statistically. Nasr 2009 and case literature document several acute hepatic failures and acute kidney injuries in young men under superdrol at recreational doses (10-20 mg/d × 3-4 weeks), sometimes requiring hospitalization and dialysis. No other commercialized oral generates as many reports for such modest doses. Probable origin: combination of 17α methylation + 2,17α-dimethyl modification that saturates hepatic detoxification pathways more than other compounds and increases cholestasis risk.
Why was superdrol pulled from the market?: Initially sold as 'legal prohormone' under American legislative loophole in the 2000s, the FDA and DEA reclassified it as a controlled substance after accumulation of serious adverse event cases (cholestasis, hepatic failure, kidney failure, malignant hypertension). The compound remains accessible on the underground market and in some 'gray market' supplements, often under various commercial names. Its anti-doping classification is total (banned in and out of competition).
How much realistic gains with superdrol?: Over 4 weeks at 15 mg/d as kickstart of a 500 mg/week testo cycle: +4 to +7 kg raw mass, with little water retention ('dry' effect). Net gains retained at 3 months post-PCT: +3 to +5 kg of real muscle attributable to superdrol alone. It is very effective per mg, but the risk/benefit ratio is unfavorable compared to a dianabol 30 mg/d kickstart (net gains +2-3 kg with less severe hepatic profile).
Do you need hepatoprotectors under superdrol?: Imperative. TUDCA 500-1000 mg/d (the most documented for 17α-alkylated cholestasis), NAC 600 mg × 2 (hepatocyte regeneration), milk thistle 600 mg. These supplements do not prevent toxicity but can attenuate cholestasis and accelerate regeneration. Biological monitoring (ALT, AST, GGT, weekly total and direct bilirubin) remains non-negotiable. Any ALT elevation > 5× normal or bilirubin > 2× requires immediate stop.
Does anadrol also cause renal problems?: Less frequently than superdrol, but yes. The marked water retention and hypertension induced by anadrol can stress renal function, especially in users already with borderline eGFR. Documented cases of glomerulonephritis and acute kidney injury on anadrol cycles at 100+ mg/d in users who also consumed excess creatine and insufficient water. Creatinine and eGFR monitoring at W0, W2, W4 under high-dose anadrol cycle.
PCT after superdrol or anadrol cycle?: Intensive scheme. Start 3-4 days after last intake. hCG 1500 IU EOD × 10 days to restart atrophied testicles. Then clomid 50/50/25/25 mg × 4-6 weeks + nolvadex 20/20/10/10 mg (essential after anadrol to block indirect estrogenic rebounds on withdrawal). Complete panel T total, LH, FSH, E2, ALT/AST at W6 post-PCT. Imperative 12+ week hepatic break before any new oral. Cycle resumption only after complete hepatic panel back to normal.
Is there a safer alternative to superdrol?: For 'dry' kickstart without retention: turinabol 40-60 mg/d × 6 weeks offers 70% of superdrol effect with markedly more tolerable hepatic profile (still toxic but without documented extreme cases). For more potent mass kickstart: anadrol 50 mg/d × 4 weeks at high but documented/manageable hepatic risk. Superdrol is only justified in tight competition accepting the inherent risk — for recreational use, safer alternatives exist.
What specific renal monitoring under superdrol?: Creatinine and eGFR panel at W0 and every 2 weeks during cycle. Monitor microscopic hematuria (urine strip), low back pain, foamy urine (proteinuria). Hydration is critical: minimum 4 L of water per day, strict restriction of creatine and renal supplements. Any sign (pain, oliguria, dark urine) should lead to immediate stop with nephrology consultation. Superdrol renal toxicity appears cumulative and sometimes irreversible in some users.

Superdrol vs Anadrol: complete comparison (extreme orals, mass)

Critère	superdrol	anadrol
Anabolic/androgenic ratio	400:20	320:45
Half-life	~6-8 h	~9 h
Aromatization	No	No (but indirect estro effect)
Water retention	Minimal	Very marked
Hepatotoxicity	EXTREME (cases cholestasis + AKI)	Very high
Typical dose	10-20 mg/d	50-100 mg/d
Max duration	3-4 weeks	3-4 weeks
Gains 4 wk	+4-7 kg (dry)	+6-10 kg (wet + retention)

Quand choisir superdrol

Quand choisir anadrol

Combinaison ?

FAQ

Is superdrol really more dangerous than other orals?: Yes, statistically. Nasr 2009 and case literature document several acute hepatic failures and acute kidney injuries in young men under superdrol at recreational doses (10-20 mg/d × 3-4 weeks), sometimes requiring hospitalization and dialysis. No other commercialized oral generates as many reports for such modest doses. Probable origin: combination of 17α methylation + 2,17α-dimethyl modification that saturates hepatic detoxification pathways more than other compounds and increases cholestasis risk.
Why was superdrol pulled from the market?: Initially sold as 'legal prohormone' under American legislative loophole in the 2000s, the FDA and DEA reclassified it as a controlled substance after accumulation of serious adverse event cases (cholestasis, hepatic failure, kidney failure, malignant hypertension). The compound remains accessible on the underground market and in some 'gray market' supplements, often under various commercial names. Its anti-doping classification is total (banned in and out of competition).
How much realistic gains with superdrol?: Over 4 weeks at 15 mg/d as kickstart of a 500 mg/week testo cycle: +4 to +7 kg raw mass, with little water retention ('dry' effect). Net gains retained at 3 months post-PCT: +3 to +5 kg of real muscle attributable to superdrol alone. It is very effective per mg, but the risk/benefit ratio is unfavorable compared to a dianabol 30 mg/d kickstart (net gains +2-3 kg with less severe hepatic profile).
Do you need hepatoprotectors under superdrol?: Imperative. TUDCA 500-1000 mg/d (the most documented for 17α-alkylated cholestasis), NAC 600 mg × 2 (hepatocyte regeneration), milk thistle 600 mg. These supplements do not prevent toxicity but can attenuate cholestasis and accelerate regeneration. Biological monitoring (ALT, AST, GGT, weekly total and direct bilirubin) remains non-negotiable. Any ALT elevation > 5× normal or bilirubin > 2× requires immediate stop.
Does anadrol also cause renal problems?: Less frequently than superdrol, but yes. The marked water retention and hypertension induced by anadrol can stress renal function, especially in users already with borderline eGFR. Documented cases of glomerulonephritis and acute kidney injury on anadrol cycles at 100+ mg/d in users who also consumed excess creatine and insufficient water. Creatinine and eGFR monitoring at W0, W2, W4 under high-dose anadrol cycle.
PCT after superdrol or anadrol cycle?: Intensive scheme. Start 3-4 days after last intake. hCG 1500 IU EOD × 10 days to restart atrophied testicles. Then clomid 50/50/25/25 mg × 4-6 weeks + nolvadex 20/20/10/10 mg (essential after anadrol to block indirect estrogenic rebounds on withdrawal). Complete panel T total, LH, FSH, E2, ALT/AST at W6 post-PCT. Imperative 12+ week hepatic break before any new oral. Cycle resumption only after complete hepatic panel back to normal.
Is there a safer alternative to superdrol?: For 'dry' kickstart without retention: turinabol 40-60 mg/d × 6 weeks offers 70% of superdrol effect with markedly more tolerable hepatic profile (still toxic but without documented extreme cases). For more potent mass kickstart: anadrol 50 mg/d × 4 weeks at high but documented/manageable hepatic risk. Superdrol is only justified in tight competition accepting the inherent risk — for recreational use, safer alternatives exist.
What specific renal monitoring under superdrol?: Creatinine and eGFR panel at W0 and every 2 weeks during cycle. Monitor microscopic hematuria (urine strip), low back pain, foamy urine (proteinuria). Hydration is critical: minimum 4 L of water per day, strict restriction of creatine and renal supplements. Any sign (pain, oliguria, dark urine) should lead to immediate stop with nephrology consultation. Superdrol renal toxicity appears cumulative and sometimes irreversible in some users.